Fen Zhang Reports 5.7% Stake in Eureka Acquisition Corp

TL;DR

**FEN ZHANG NOW OWNS 5.7% OF EUREKA ACQUISITION CORP (EURE)**

AI Summary

On July 3, 2024, Fen Zhang, CEO of Eureka Acquisition Corp, filed a Schedule 13D. Zhang, through Hercules Capital Management Corp, reported beneficial ownership of 1,150,000 ordinary shares, representing 5.7% of the outstanding shares. This filing indicates a significant stake in the blank check company.

Why It Matters

This filing signals a substantial ownership position by a key executive in a special purpose acquisition company (SPAC), potentially influencing future merger or acquisition activities.

Risk Assessment

Risk Level: medium — The filing indicates a significant stake by an executive, which could signal upcoming strategic moves or potential changes in control for the SPAC.

Key Numbers

• 1,150,000 — Shares Owned (Represents beneficial ownership by Fen Zhang.)
• 5.7% — Ownership Percentage (Indicates the proportion of Eureka Acquisition Corp controlled by Fen Zhang.)

Key Players & Entities

• Fen Zhang (person) — CEO and beneficial owner
• Eureka Acquisition Corp (company) — Issuer of securities
• Hercules Capital Management Corp (company) — Filing entity for beneficial ownership
• 1,150,000 (dollar_amount) — Number of ordinary shares owned
• 5.7% (dollar_amount) — Percentage of outstanding shares owned

FAQ

Key Financial Figures

• $0.0001 — of Issuer) Ordinary Share, par value $0.0001 per share (Title of Class of Securitie
• $25,000 — ares for an aggregate purchase price of $25,000. On July 1, 2024, the Sponsor transfer
• $10.00 — , the Sponsor acquired 228,000 units at $10.00 per unit, each unit consisting of one C

Filing Documents

• ea0208961-13dhercules_eureka.htm (SC 13D) — 58KB
• ea020896101ex7-1_eureka.htm (EX-7.1) — 3KB
• ea020896101ex10-1_eureka.htm (EX-10.1) — 22KB
• ea020896101ex10-2_eureka.htm (EX-10.2) — 58KB
• 0001213900-24-059026.txt ( ) — 143KB

(d) oI(e)

Item 2(d) oI(e) 6 Citizenship or place of organization British Virgin Islands Number of shares beneficially owned by each reporting person with 7 Sole voting power 1,635,500 (1)(2) 8 Shared voting power 9 Sole dispositive voting power 1,635,500 (1)(2) 10 Shared dispositive power 11 Aggregate amount beneficially owned by each reporting person 1,635,500 (1)(2) 12 Check box if the aggregate amount in row (11) excludes certain shares* 13 Percent of class represented by amount in row (11) 21.4% 14 Type of reporting person* CO (1) It includes (i) 228,000 Class A ordinary share, par value $0.0001 per share (the “Class A Ordinary Shares”) that Hercules Capital Management Corp (the “Sponsor”) acquired in a private placement simultaneously with the consummation of the initial public offering on July 3, 2024 (including up to 11,250 units to purchase upon the underwriters’ exercise of over-allotment option), and (ii) 1,407,500 Class B ordinary shares, par value $0.0001 per share (the “Class B Ordinary Shares”) that the Sponsor acquired on September 29, 2023. Class B Ordinary Shares will automatically convert into Class A Ordinary Shares on one-for-one basis upon the consummation of an initial business combination, subject to certain adjustments as provided in the second amended and restated memorandum and articles of association of the Issuer. (2) The Sponsor is the record holder of the shares reported herein. Dr. Fen Zhang is the sole director and sole shareholder of the Sponsor. As such, Dr. Zhang is deemed to hold voting and dispositive control over the securities held directly by the Sponsor. 1 SCHEDULE 13D CUSIP No. G32168 109 1 Name of reporting persons I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Fen Zhang 2 Check the appropriate box if a member of a group* (a) (b) 3 SEC use only 4 Source of funds* OO 5 Check box if disclosure of legal proc

of the Schedule 13D is hereby amended by adding the following

Item 7 of the Schedule 13D is hereby amended by adding the following to the end of the section: Exhibit No. Description 7.1 Joint Filling Agreement, dated July 3, 2024 10.1 Securities Transfer Agreement dated June 27, 2024 by and among the Issuer, the Sponsor and certain directors of the Issuer 10.2 Private Placement Units Purchase Agreement dated July 2, 2024 between the Sponsor and the Issuer. 5 SCHEDULE 13D CUSIP No. G32168 109

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of our knowledge and belief, we certify that the information set forth in this statement is true, complete and correct. Date: July 3, 2024 Hercules Capital Management Corp By: /s/ Fen Zhang Name: Fen Zhang Title: Sole Director Fen Zhang /s/ Fen Zhang 6

View Full Filing

View this SC 13D filing on SEC EDGAR